Production processClosed Production

Products 1 to 10 of 174

Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA + Sweden + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/08/30 11:49 (9 months ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Accellerase TRIO by DuPont + Genencor
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/09/20 09:09 (8 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Acrylic Acid by GC Innovation America + Myriant
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/10/02 15:42 (8 months ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Adipic Acid by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/11/08 14:50 (7 months ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/10/01 10:00 (8 months ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/08/30 11:49 (9 months ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Food & Agriculture
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: Netherlands
Country of distribution: USA + Netherlands
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/10/01 09:58 (8 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Closed Production
Source: NASEM Database
Trading symbol: CRBN (AEX)
Value chain stage: Finished Product
Antibiotic - EV-035 by Emergent Biosolutions, Inc.
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA + Switzerland
Intended consumer: Government
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/08/30 11:49 (9 months ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
Archetype: Sequence Genome Anotation Software by SGI-DNA + Synthetic Genomics
Biotech components: N/A
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/09/28 16:59 (8 months ago)
Known funding amount: 40,000,000 USD
Funding types: Venture Capital
Industry: Science
Market status: On the market
Organization type(s): Private Company
Product categories: Design
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Arsenic Whole-cell Biosensors by Bielefield-CeBiTech
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: Germany
Country of distribution: Germany
Intended consumer: Consumer + Commercial + Government
Date added: 2018/08/30 11:49 (9 months ago)
Date last modified: 2018/08/30 11:49 (9 months ago)
Known funding amount: N/A
Funding types: Government
Industry: Science
Market status: Early Stage Concept
Organization type(s): University + Research Institution
Product categories: Research
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product